John Mak Selected Research

CK0106023

5/2004

Antitumor activity of a kinesin inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Mak Research Topics

Disease

2	Pain (Aches) 11/2019 - 01/2019
1	Chronic Pain 11/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Calcinosis Cutis 01/2007
1	Necrosis 01/2007
1	Cardiomyopathies (Cardiomyopathy) 09/2004
1	Fibrosis (Cirrhosis) 09/2004
1	Neoplasms (Cancer) 05/2004

Drug/Important Bio-Agent (IBA)

1	CalciumIBA 01/2007
1	Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric 01/2007
1	SaltsIBA 01/2007
1	RelaxinIBA 09/2004
1	relaxin receptorsIBA 09/2004
1	CollagenIBA 09/2004
1	KinesinsIBA 05/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2004
1	Proteins (Proteins, Gene)FDA Link 05/2004
1	Antimitotic AgentsIBA 05/2004
1	CK0106023IBA 05/2004

Therapy/Procedure

2	Surgical Amputation (Amputations) 11/2019 - 01/2019
2	Therapeutics 01/2019 - 05/2004
1	Intravenous Administration 01/2007